About Us / MCC Multi-center Interest Group

MCC Multi-center Interest Group

Who we are

We are a group of 198 physicians, surgeons, pathologists, virologists, scientists and medical students based in medical institutions across the world who are committed to:

  • Promoting communication and collaborative studies on MCC.
  • Enhancing access to patient data and specimens.
  • Expanding evidence-based care for MCC.

Featured here are some of the current MMIG members. Click here to view more photos of MMIG members.

MMIG Meetings

Upcoming Meetings

We will hold the 2021 Multicenter Merkel Interest Group (MMIG) meeting on Friday, June 4th, 11 am-1 pm EDT / 8 am-10 am PDT via Zoom Please email mccteam@uw.edu for an invitation with the zoom details. If you have an interesting topic to present, please let us know as we have a few available spots. The tentative agenda is below.

Tentative agenda:

Jürgen Becker, MD/PhD Molecular characterization of classical and variant MCC cell lines (University of Duisburg-Essen)

Natasha Hill, PhD Repurposing disulfiram for the treatment of MCC (National Institutes of Health, Isaac Brownell lab)

Yassi Moshiri, MD MCC Immunotherapy responders after treatment discontinuation: A potentially concerning recurrence rate? (University of Washington, Nghiem lab)

Lisa Zaba, MD/PhD Circulating tumor DNA as a biomarker for MCC tumor burden (Stanford University)

Michael Wong, MD/PhD MDM2 Inhibitor [KRT-232] Therapy in p53 WT MCC Patients Refractory to PD-1/1L Immunotherapy: preliminary results and observations (MD Anderson Cancer Center)

– Review plans for 2nd International MCC Symposium; targeting early 2022


Past Meetings

The MMIG meets yearly in various cities around the world. Click on a meeting year to access the summary of that year’s minutes.

Current MMIG Members

Click here to view photos of MMIG members.

Centers with established, multi-disciplinary MCC treatment programs are in BOLD. 

United States


  • Charite University Hospital, Berlin, Germany
  • Julius Maximilians University, Wuerzburg, Germany
  • Osaka City University School of Medicine, Osaka, Japan
  • Saga University Medical School, Saga, Japan
  • Sahlgrenska University Hospital, Gothenburg, Sweden
  • Sydney Melanoma Unit, Sydney, Australia
  • Tel Aviv University, Tel Aviv, Israel
  • Universidad Complutense, Madrid, Spain
  • Universidad Pontificia Bolivariana, Colombia, S America
  • University Hospital of Birmingham, Birmingham, UK
  • University of Sydney, Sydney, Australia
  • University of Turin, Turin, Italy
  • University of Versailles, Paris, France
  • Westmead Hospital, Sydney, Australia